Neoplasia/BPH

	Feasibility of opportunistic bone health assessment using low-dose CT trabecular attenuation and (18)F-NaF uptake from PET/CT in prostate cancer. Front Endocrinol (Lausanne) Liu C, Liang F, Li Z, Wang Z, Fu W, Mu X. PMID: 42548567 [PubMed - indexed for MEDLINE]
	Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1. Kidney Res Clin Pract Petrovic V, Malkov VA, Billin AN, Patel UD, Pergola PE, Chertow GM, Skupien J, Krolewski AS. PMID: 42548168 [PubMed - as supplied by publisher]
	Early Physiologic Deobstruction After 980-nm Diode-Laser Contact Prostate Vaporization: Analysis of Evaluable Paired Pressure-Flow Studies From a Consecutive Cohort. Low Urin Tract Symptoms Kurano Y, Shimizu N, Ide Y, Togo M, Yoshimura R, Shigehisa R, Yamamoto S, Fukuhara H, Fukata S, Saito M, Inoue K. PMID: 42548029 [PubMed - indexed for MEDLINE]
	Image-based evaluation of a commercial AI synthetic CT generator for brain and prostate MR-only radiotherapy. J Appl Clin Med Phys Aire M, Matthews C, Jones J, Duong D, Schneider C, Stathakis S, Shay O, Kirby K. PMID: 42547906 [PubMed - indexed for MEDLINE]
	Artificial intelligence empowers full-stack histopathological diagnosis and prognosis of renal cell tumor: a multi-center study with external validation. BMC Med Xiong Y, Xi W, Zhang G, Luo X, Xiao L, Gao J, Wang R, Wang K, Zhao Y, Sun Q, Wang Z, Guo J, Qu L, Hou Y, Zhao D, Wang S. PMID: 42547870 [PubMed - indexed for MEDLINE]
	Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care. Prostate Cancer Prostatic Dis Sibona M, Kuang W, Gontero P, Secco S, Cindolo L. PMID: 42547540 [PubMed - as supplied by publisher]
	Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations. Prostate Cancer Prostatic Dis Ditonno F, Veccia A, Bernardino RM, Brunelli M, Cindolo L, Ferrari G, Falagario U, Nguyen JK, Autorino R, Bertolo R, Antonelli A. PMID: 42547539 [PubMed - as supplied by publisher]
	Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancer. Urol Oncol Paras G, Schweizer MT. PMID: 42547387 [PubMed - as supplied by publisher]
	Prognostic value of different biomarkers in bladder cancer: protocol for an umbrella review of systematic reviews and meta-analyses. BMJ Open Aghamir SMK, Rahimnia R, Taheri D, Ebrahimi M, Talebian MT, Keshtkar A, Ghasemi M, Mohammadi SD, Menbari Oskouie I, Nikoofar P, Khatami F. PMID: 42547229 [PubMed - indexed for MEDLINE]
	Contemporary Updates on Subtypes of Prostate Cancer. Arch Pathol Lab Med Jia L, Yang XJ. PMID: 42547080 [PubMed - as supplied by publisher]
	Radiotherapy strategies for prostate cancer: Techniques, outcomes, and patient care. Cancer Treat Res Commun Khalaji A, Ghazi F, Alivirdiloo V, Abosaoda MK, Kashyap A, T S, Ray S, Sharma A, Mobed A. PMID: 42546529 [PubMed - as supplied by publisher]
	Cross-cohort projection of clinically anchored latent risk enables multi-omics interpretation without refitting. Brief Bioinform Huang Z, Cai Y, Gao X, Hu S, Tang Y, Chen M. PMID: 42546047 [PubMed - indexed for MEDLINE]
	Artificial intelligence in the radiologic diagnosis of major urological cancers: a meta-analysis. World J Urol Shen Y, Peng L, Gan L, Wu S. PMID: 42545470 [PubMed - indexed for MEDLINE]
	Pelvic lymph node dissection during robot-assisted radical prostatectomy: a bibliometric analysis of surgical extent, nodal staging, and lymphatic morbidity. J Robot Surg Zhao Y, Wang W, Dong Z. PMID: 42545410 [PubMed - indexed for MEDLINE]
	Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden. Scand J Urol Hawez L, Bergengren O, Ahlberg M, Garmo H, Van Hemelrijck M, Nyberg UK, Gardmark T, Holmberg L, Liedberg F, Bill-Axelson A. PMID: 42545334 [PubMed - indexed for MEDLINE]
	The PROTEUS trial: envisioning the future of perioperative therapy and radical prostatectomy for high-risk prostate cancer. Official position of the Italian Society of Urology (SIU). Minerva Urol Nephrol Novara G, Albisinni S, Campi R, Larcher A, DE Lorenzis E, Pandolfo SD, Pavan N, Zattoni F, Dal Moro F, Antonelli A, Ficarra V, Minervini A, Mirone V, Rocco B, Salonia A, Tubaro A, Carrieri G, Porpiglia F. PMID: 42545136 [PubMed - as supplied by publisher]
	Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation. Int J Urol Abe K, Miyazawa Y, Nakazawa S, Onose M, Maeno Y, Tsuji Y, Kanayama A, Ohtsu A, Fujizuka Y, Arai S, Nomura M, Sekine Y, Koike H, Matsui H, Suzuki K. PMID: 42544862 [PubMed - indexed for MEDLINE]
	Present status of prostate cancer diagnosis, limitations, challenges, and future endeavors. Ann Med Hooda K, Chatterjee M, Sharma AP, Aggarwal N, Sharma J. PMID: 42544420 [PubMed - indexed for MEDLINE]
	Cultural Factors Influencing Prostate Cancer Screening Uptake in Urban Ogun State, Nigeria: A Review of Evidence. Niger Med J Aluko-Arowolo S, Oyafunke-Omoniyi C, Tamuno-Opubo AT, Tobi AA, Nwaobilor OS. PMID: 42544271 [PubMed]
	[The diagnostic complexity of paraneoplastic thrombotic thrombocytopenic purpura]. Rev Med Liege Delcour A, Jadot L, Aït Moussa N, Herman L, Perlot Q. PMID: 42544062 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 190227

Page 1 of 9512



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy